Drug profile · INN
benazepril hydrochloride
BENAZEPRIL HYDROCHLORIDE
benazepril hydrochloride (BENAZEPRIL HYDROCHLORIDE) is a angiotensin-converting enzyme inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — benazepril hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 0
- Data quality
- 0.89
Quick answer
benazepril hydrochloride (BENAZEPRIL HYDROCHLORIDE) is a angiotensin-converting enzyme inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Angiotensin-converting enzyme inhibitor
Primary target: Angiotensin-converting enzyme
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
Frequently asked questions
What is benazepril hydrochloride?
benazepril hydrochloride (BENAZEPRIL HYDROCHLORIDE) is a angiotensin-converting enzyme inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for benazepril hydrochloride?
BENAZEPRIL HYDROCHLORIDE is a marketed brand name for benazepril hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of benazepril hydrochloride?
benazepril hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.